Crystal Biotech Tombstone

Custom crystal tombstone marking a public offering by Cytomx Therapeutics. The clinical-stage oncology-focused biopharmaceutical firm is based in South San Francisco. Goldman Sachs, Citigroup, and Barclays served as joint bookrunning managers for the offering.